Microneedle Drug Delivery Systems Market Share

North American Market Forecast

The market in the North American region is anticipated to develop faster owing to the rise in the adoption of highly advanced processes and systems for the manufacture of microneedles and the technical improvements made in microneedle drug delivery. The significant market growth in the area is mostly attributed to the increased knowledge among the populace about the existence of revolutionary microneedle medication delivery systems on the market. The market for microneedle drug delivery system in this region is also anticipated to increase owing to the rising prevalence of chronic diseases among Americans. In the United States, 37.3 million people were determined to have diabetes in 2020, while 96 million adults were found to have pre-diabetes, according to the National Diabetes Statistics Report. About 36 million persons in the United States are anticipated to have chronic renal illnesses in 2020, according to the National Kidney Foundation. According to research from the Centers for Conditions Control and Prevention in 2020, around 15.7 million Americans suffer from a chronic lower respiratory disease. Further, it is anticipated that the prevalence of chronic diseases among Americans will accelerate the growth of the North American microneedle drug delivery systems market. As a result, it is anticipated that growing investments in the healthcare sector and rising awareness of the significance of microneedle drug delivery systems will fuel the market's expansion in this area.

APAC Market Statistics

Furthermore, the Asia Pacific region is anticipated to expand quickly owing to factors such as population growth, changing lifestyles, increased patient awareness, and rising per capita spending. Additionally, developing nations such as China and India can strengthen their healthcare systems thanks to economic development and advances in cosmetic items' efficacy.